Skip to content

The study of the whole body vibration therapy effects on the patients with knee osteoarthritis.

The study of the Whole Body Vibration Therapy effects on Pain , Knee Range of Motion, Functional Activities, Electromyography Muscles Activity of the Lower Limbs and Postural Stability of Patients with Knee Osteoarthritis.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201601171637N5
Enrollment
45
Registered
2016-04-03
Start date
2016-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis. Other primary gonarthrosis

Interventions

Intervention 1: The whole body vibration training group will do their intervention on a vibration platform .The WBVT programme will be done on the Fitvibe vertical vibration platform with amplitude o
Rehabilitation
The whole body vibration training group will do their intervention on a vibration platform .The WBVT programme will be done on the Fitvibe vertical vibration platform with amplitude of 3 mm and frequ
The patient in placebo group will do their intervention on a vibration platform as WBVT group while the vibration system is off and does not transmit any vibration to the patient's feet while standing
The practice at home group will be educated to do two exercises in three set with ten repetitions and a five-second hold for each exercise and a five-second pause. The exercise program of the group wi

Sponsors

Vice chancellor for research-Tarbiat Modares University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria: Knee OA with Kellgren–Lawrence grade II and III in simple X-ray; between 55-75 years old; no previous or concomitant injury on the knee and other lower extremity joints; no previous history of serious knee trauma, surgery and arthroplasty; no history of knee intra-articular injection of hyaluronic acid or steroid in the last 6 months; no history of surgery or traumatic injuries to the lower limbs; no history of medical problems such as cardiopulmonary diseases, neurologic diseases, malignant diseases, chronic diseases such as diabetes; no history of newly repaired fracture and bone implants; no pacemaker and no history of WBVT contraindications for participants of the WBVT group; The exclusion criteria: Any systemic disorder in the body, according to the patient and physician; taking any medication according to the patient; incomplete treatment and assessment; WBVT intolerance for the WBVT group;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Pre and post intervention. Method of measurement: Visual Analogue Scale for pain( 100 mm Ruler).;Knee Range of Motion. Timepoint: Pre and post intervention. Method of measurement: Goniometery in degree.;Time up & Go test. Timepoint: Pre and post intervention. Method of measurement: Chronometer ( sec).;6 minute walk test. Timepoint: Pre and post intervention. Method of measurement: Meter.;Electromyographic (EMG) root mean square (RMS) response of some lower limb muscles during maximum voluntary isometric contraction. Timepoint: Pre and post intervention. Method of measurement: Electromygraphy.;Overall Sway Index. Timepoint: Pre and post intervention. Method of measurement: Biodex Balance System.;Antroposterior Sway Index. Timepoint: Pre and post intervention. Method of measurement: Biodex Balance System.;Medilateral Sway Index. Timepoint: Pre and post intervention. Method of measurement: Biodex Balance System.

Secondary

MeasureTime frame
Anteroposterior Sway. Timepoint: pre andp post intervention. Method of measurement: Forceplate.;Sway Average Velocity. Timepoint: pre andp post intervention. Method of measurement: Forceplate.;Mediolateral Sway. Timepoint: pre andp post intervention. Method of measurement: Forceplate.

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Ebrahim Abbasi

Tarbiat Modares University

ebiabasi@yahoo.com+98 21 8288 4511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026